News

FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...
The flu vaccine is crucial, especially for older adults, heart patients, and children, as the flu can lead to severe ...
AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...
If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...
AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...
On an earnings call, CSL CEO Paul McKenzie described weakness in the U.S. market for seasonal flu vaccines as “disappointing” ...
The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...
(Reuters) -Australian biotech giant CSL Ltd on Tuesday announced plans to demerge its influenza vaccine division, CSL Seqirus, and said it will lay off up to 15% of its workforce, after reporting a ...
HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...